Abbott Laboratories stated their new test is the fastest test in the world
An emergency authorization was given by The Food and Drug Administration (FDA) on Friday for a new coronavirus test that can produce results in as little as 5 minutes, and small enough to be used anywhere.
Abbott Laboratories stated their new test is the fastest test in the world and can deliver “positive results in as little as five minutes and negative results in 13 minutes.”
Abbott Laboratories said in a statement:
“The test will run on the company’s ID NOW™ platform, providing rapid results in a wide range of healthcare settings such as physicians’ offices, urgent care clinics, and hospital emergency departments.”
“The ID NOW platform is small, lightweight (6.6 pounds) and portable (the size of a small toaster), and uses molecular technology, which is valued by clinicians and the scientific community for its high degree of accuracy.”
“ID NOW is already the most widely available molecular point-of-care testing platform in the U.S. today.”
Robert B. Ford, president, and chief operating officer of Abbot said:
“The COVID-19 pandemic will be fought on multiple fronts, and a portable molecular test that offers results in minutes adds to the broad range of diagnostic solutions needed to combat this virus.”
“With rapid testing on ID NOW, healthcare providers can perform molecular point-of-care testing outside the traditional four walls of a hospital in outbreak hotspots.”
This is GAME CHANGER. Abbott to market, starting next week, a fast point-of-care #coronavirus test, delivering positive results in 5min and negative results in 13min. Will deliver 50K tests/day to start. Kudos to Abbott and FDA’s Jeff Shuren and team at CDRH who are in the fight.
— Scott Gottlieb, MD (@ScottGottliebMD) March 28, 2020
WATCH: Cuomo Admits Stockpile of Ventilators that Have Not Been Distributed to Hospitals Yet
READ MORE: https://t.co/0vE6yGcNsd
— Neon Nettle (@NeonNettle) March 28, 2020
The company also plans to begin providing 50,000 of the newly approved tests per day for official use, CNBC reported.
“The arrival of the Abbott ID NOW COVID-19 test comes a week after the company launched its Abbott m2000™ RealTime SARS-CoV-2 EUA test, which runs on the m2000™ RealTime System located in hospital and reference labs around the world,” the company added.
“Between the two platforms, Abbott expects to produce about 5 million tests per month.”
Scott Gottlieb, MD, the former FDA Commissioner, said the tests would be a game-changer in the Trump administration’s fight against the Chian originated coronavirus.
Gottlieb wrote on Twitter:
“This is GAME CHANGER.”
“Abbott to market, starting next week, a fast point-of-care #coronavirus test, delivering positive results in 5min and negative results in 13min. Will deliver 50K tests/day to start. Kudos to Abbott and FDA’s Jeff Shuren and team at CDRH who are in the fight.”